Abstract
To improve the understanding of diphosphonate affinity to metabolically active bone, the underlying diphosphonate kinetics have been evaluated and compared to Cr-EDTA kinetics. MDP binds to plasma proteins, varying from 25% initially to approximately 70% after 24 h. The renal clearance of diphosphonate is found to be equal to Cr-EDTA clearance. Using simultaneous bolus injection of 99Tc-MDP and 51Cr-EDTA, it has been possible to obtain a coarse estimate of bone uptake of MDP. This uptake is found to correlate well with s-alkaline phosphatase, but since MDP binding to bone is reversible, the plasma elimination curve is not monoexponential. Therefore it has not been possible to describe the uptake of MDP in bone mathematically.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Castronovo FP Jr (1980) Normal pharmacokinetics of 99m Tc-diphosphonate after intravenous administration. Biopharm Drug Dispos 2:283–389
Fogelman I, Bessent RG, Citrin DL, Boyle IT, Greig WR (1978) The use of whole body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med 19:270–275
Fogelman I, Bessent RG, Scullion JE, Cuthbert GF (1982) Accuracy of 24-h whole body (skeletal) retention of diphosphonate measurements. Eur J Nucl Med 7:359–363
Hyldstrup L, McNair P, Jensen GF, Mogensen NB, Transbøl I (1984) Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency on age, sex and glomerular filtration? Scand J Lab Clin Invest 44:673–678
Knop J, Kroger E, Stritzke P, Schneider C, Kruse HP (1981) Deconvolution analysis of 99m-Tc-methylene diphosphonate kinetics in metabolic bone disease. Eur J Nucl Med 6:63–67
Mele M, Conte E, Fratello A, Pasculli D, Pieralice M, D'Addabbo A (1983) Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication. J Nucl Med 24:334–338
Subramanian G, McAfee JG, Bell EG, Blair RJ, O'Mara RE, Ralston PH (1972) 99m-Tc-labeled polyphosphate as a skeletal imaging agent. Radiology 102:701–704
Subramanian G, McAfee JG, Blair RJ, Kallfelz FA, Thomas FD (1975) Technetium-99m-methylene diphosphonate—a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med 16:744–755
Todd Makler P Jr, David Charkes N (1980) Studies of skeletal tracer kinetics IV. Optimum delay time for Tc-99m (Sn) methylene diphosphonate bone imaging. J Nucl Med 21:641–645
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hyldstrup, L., McNair, P., Ring, P. et al. Studies on diphosphonate kinetics. Eur J Nucl Med 12, 581–584 (1987). https://doi.org/10.1007/BF00284529
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00284529